Genotype-phenotype associations in WT1 glomerulopathy

Kidney International

Volumn 85, Issue 5, 2014, Pages 1169-1178

  Lipsk, Beata S ^a,b   Ranchin, Bruno ^c   Iatropoulos, Paraskevas ^d   Gellermann, Jutta ^e   Melk, Anette ^f   Ozaltin, Fatih ^g   Caridi, Gianluca ^h   Seeman, Tomas ^i,j   Tory, Kalman ^k   Jankauskiene, Augustina ^l   Zurowska, Aleksandra ^a   Szczepanska, Maria ^m   Wasilewska, Anna ⁿ   Harambat, Jerome ^o   Trautmann, Agnes ^b   Peco Antic, Amira ^p   Borzecka, Halina ^q   Moczulska, Anna ^r   Saeed, Bassam ^s   Bogdanovic, Radovan ^t   Kalyoncu, Mukaddes ^u   Simkova, Eva ^v   Erdogan, Ozlem ^w   Vrljicak, Kristina ^x   Teixeira, Ana ^y   Azocar, Marta ^z   Schaefer, Franz ^b   Quiroz, Lily ^aa   Higuita, Lina Maria Serna ^ab   Dušek, Jiří ^aa   Fischbach, Michel ^aa   Davitaia, Tinatin ^aa   Oh, Jun ^aa   Wigger, Marianne ^aa   Fotios, Papachristou ^aa   Sallay, Peter ^aa   Gheissari, Alaleh ^aa   Remuzzi, Guiseppe ^aa   Pasini, Andrea ^aa   Ghiggeri, Gian Marco ^aa   Ardissino, Gianluigi ^aa   Benetti, Elisa ^aa   Emma, Francesco ^aa   Aoun, Bilal ^aa   Abou Jaoudé, Pauline ^aa   Hyla Klekot, Lidia ^aa   Drozdz, Dorota ^aa   Tkaczyk, Marcin ^aa   Silska, Magdalena ^aa   Jarmolinski, Tomasz ^aa   Firszt Adamczyk, Agnieszka ^aa   Ksiazek, Joanna ^aa   Kuzma Mroczkowska, Elzbieta ^aa   Medynska, Anna ^aa   Afonso, Alberto Caldas ^aa   Jardim, Helena ^aa   Krmar, Rafael T ^aa   Simonetti, Giacomo D ^aa   Anarat, Ali ^aa   Bakkaloglu, Aysin ^aa   Balat, Ayse ^aa   Baskin, Z Esra ^aa   Cakar, Nilgun ^aa   Özcakar, Birsin ^aa   Sakallioglu, Onur ^aa   Soylemezoglu, Oguz ^aa   Akman, Sema ^aa   Gok, Faysal ^ac   Caliskan, Salim ^aa   Candan, Cengiz ^aa   Emre, Sevinc ^aa   Mir, Sevgi ^aa   Akil, Ipek ^aa   Ertan, Pelin ^aa   Özkaya, Ozan ^aa   Alhammadi, Entesar ^aa   Sobko, Roman ^aa   more..

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c HOSPICES CIVILS DE LYON   (France)

^d MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^e Klinik für Pädiatrie Nephrologie   (Germany)

^f HANNOVER MEDICAL SCHOOL   (Germany)

^g HACETTEPE UNIVERSITY   (Turkey)

^h G GASLINI INSTITUTE   (Italy)

ⁱ UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^j CHARLES UNIVERSITY   (Czech Republic)

^k SEMMELWEIS UNIVERSITY   (Hungary)

^l VILNIUS UNIVERSITY   (Lithuania)

^m MEDICAL UNIVERSITY OF SILESIA   (Poland)

ⁿ UNIVERSITY OF BIALYSTOK   (Poland)

^o Centre de Référence Maladies Rénales Rares du Sud Ouest SORARE   (France)

^p UNIVERSITY CHILDREN S HOSPITAL   (Serbia)

^q MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^r JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^s Pediatric Nephrology Division   (Syrian Arab Republic)

^t Institute of Mother and Child Healthcare of Serbia   (Serbia)

^u KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

^v DUBAI HOSPITAL   (United Arab Emirates)

^w DR SAMI ULUS CHILDREN S HOSPITAL   (Turkey)

^x KBC Zagreb   (Croatia)

^y Maria Pia Children's Hospital   (Portugal)

^z UNIVERSITY OF CHILE   (Chile)

^aa NONE   (Ukraine)

^ab NONE   (Colombia)

^ac NONE   (Turkey)

more..

Author keywords

Denys Drash syndrome; Diffuse mesangial sclerosis; Focal segmental glomerulosclerosis; Frasier syndrome; Steroid resistant nephrotic syndrome; WT1

Indexed keywords

STEROID; WT1 PROTEIN; WT1 PROTEIN, HUMAN;

ARTICLE; CANCER RISK; CHILD; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; DNA BINDING; END STAGE RENAL DISEASE; FEMALE; FOCAL GLOMERULOSCLEROSIS; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE PHENOTYPE CORRELATION; GLOMERULOPATHY; GONADECTOMY; HUMAN; HUMAN TISSUE; HYPERTENSION; INTRON; KIDNEY BIOPSY; MAJOR CLINICAL STUDY; MALE; MESANGIUM SCLEROSIS; MISSENSE MUTATION; MOLECULAR PATHOLOGY; MUTATIONAL ANALYSIS; NEPHRECTOMY; NEPHROSCLEROSIS; NEPHROTIC SYNDROME; NUCLEOTIDE SEQUENCE; ONSET AGE; PREVALENCE; PRIORITY JOURNAL; SEX TRANSFORMATION; UROGENITAL TRACT MALFORMATION; CLINICAL TRIAL; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; INCIDENCE; INFANT; MULTICENTER STUDY; MUTATION; PHENOTYPE; PRESCHOOL CHILD; PROCEDURES; PROGNOSIS; REGISTER; RENAL INSUFFICIENCY, CHRONIC; RISK FACTOR; TIME;

AGE OF ONSET; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; INCIDENCE; INFANT; MALE; MUTATION; NEPHROTIC SYNDROME; PHENOTYPE; PREVALENCE; PROGNOSIS; REGISTRIES; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; TIME FACTORS; WT1 PROTEINS;

EID: 84899907617     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2013.519     Document Type: Article

References (31)

1. Benoit G, Machuca E, Antignac C. Hereditary nephrotic syndrome: a systematic approach for genetic testing and a review of associated podocyte gene mutations. Pediatr Nephrol 2010; 25: 1621-1632.
2. Hinkes BG, Mucha B, Vlangos CN et al. Nephrotic syndrome in the first year of life: two thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, and LAMB2). Pediatrics 2007; 119: e907-e919.
3. Lipska BS, Iatropoulos P, Maranta R et al. Genetic screening in adolescents with steroid resistant nephrotic syndrome. Kidney Int 2013; 84: 206-213.
4. Santin S, Bullich G, Tazon-Vega B et al. Clinical utility of genetic testing in children and adults with steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol 2011; 6: 1139-1148.
5. Coppes MJ, Huff V, Pelletier J. Denys-Drash syndrome: relating a clinical disorder to genetic alterations in the tumor suppressor gene WT1. J Pediatr 1993; 123: 673-678.
6. Morrison AA, Viney RL, Saleem MA et al. New insights into the function of the Wilms tumor suppressor gene WT1 in podocytes. Am J Physiol Renal Physiol 2008; 295: F12-F17.
7. Huff V. Wilms' tumours: about tumour suppressor genes, an oncogene and a chameleon gene. Nat Rev Cancer 2011; 11: 111-121.
8. Dome JS, Huff V. Wilms tumor. In: Pagon RA, Bird TD, Dolan CR et al. (eds). GeneReviewst (Internet). (University of Washington: Seattle, WA, 1993.
9. Royer-Pokora B, Beier M, Henzler M et al. Twenty-four new cases of WT1 germline mutations and review of the literature: genotype/phenotype correlations for Wilms tumor development. Am J Med Genet A 2004; 127A: 249-257.
10. Barbaux S, Niaudet P, Gubler MC et al. Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nat Genet 1997; 17: 467-470.
11. Mucha B, Ozaltin F, Hinkes BG et al. Mutations in the Wilms tumor 1 gene cause isolated steroid resistant nephrotic syndrome and occur in exons 8 and Pediatr Res 2006; 59: 325-331.
12. Chernin G, Vega-Warner V, Schoeb DS et al. Genotype/phenotype correlation in nephrotic syndrome caused by WT1 mutations. Clin J Am Soc Nephrol 2010; 5: 1655-1662.
13. Kö hler B, Biebermann H, Friedsam V et al. Analysis of the Wilms' tumor suppressor gene (WT1) in patients 46,XY disorders of sex development. J Clin Endocrinol Metab 2011; 96: E1131-E1136.
14. Mestrallet G, Bertholet-Thomas A, Ranchin B et al. Recurrence of a dysgerminoma in Frasier syndrome. Pediatr Transplant 2011; 15: e53-e55.
15. Gellermann J, Stefanidis CJ, Mitsioni A et al. Successful treatment of steroid-resistant nephrotic syndrome associated with WT1 mutations. Pediatr Nephrol 2010; 25: 1285-1289.
16. Wasilewska AM, Kuroczycka-Saniutycz E, Zoch-Zwierz W. Effect of cyclosporin A on proteinuria in the course of glomerulopathy associated with WT1 mutations. Eur J Pediatr 2011; 170: 389-391.
17. Stefanidis CJ, Querfeld U. The podocyte as a target: cyclosporin A in the management of the nephrotic syndrome caused by WT1 mutations. Eur J Pediatr 2011; 170: 1377-1383.
18. Kaltenis P, Schumacher V, Jankauskiene A et al. Slow progressive FSGS associated with an F392L WT1 mutation. Pediatr Nephrol 2004; 19: 353-356.
19. Hakan N, Aydin M, Erdogan O et al. A novel WT1 gene mutation in a newborn infant diagnosed with Denys-Drash syndrome. Genet Couns 2012; 23: 255-261.
20. Wasilewska A, Zoch-Zwierz W, Tenderenda E et al. [WT1 mutation as a cause of progressive nephropathy in Frasier syndrome-case report]. Pol Merkur Lekarski 2009; 26: 642-644.
21. Schumacher V, Thumfart J, Drechsler M et al. A novel WT1 missense mutation presenting with Denys-Drash syndrome and cortical atrophy. Nephrol Dial Transplant 2006; 21: 518-521.
22. Fencl F, Malina M, Stara V et al. Discordant expression of a new WT1 gene mutation in a family with monozygotic twins presenting with congenital nephrotic syndrome. Eur J Pediatr 2012; 171: 121-124.
23. Denamur E, Bocquet N, Baudouin V et al. WT1 splice-site mutations are rarely associated with primary steroid-resistant focal and segmental glomerulosclerosis. Kidney Int 2000; 57: 1868-1872.
24. Ruf RG, Schultheiss M, Lichtenberger A et al. Prevalence of WT1 mutations in a large cohort of patients with steroid-resistant and steroid-sensitive nephrotic syndrome. Kidney Int 2004; 66: 564-570.
25. Weiss TC, Romaniuk PJ. Contribution of individual amino acids to the RNA binding activity of the Wilms' tumor suppressor protein WT1. Biochemistry 2009; 48: 148-155.
26. Borel F, Barilla KC, Hamilton TB et al. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1. Biochemistry 1996; 35: 12070-12076.
27. Koziell A, Grundy R. Frasier and Denys-Drash syndromes: different disorders or part of a spectrum? Arch Dis Child 1999; 81: 365-369.
28. Barbosa AS, Hadjiathanasiou CG, Theodoridis C et al. The same mutation affecting the splicing of WT1 gene is present on Frasier syndrome patients with or without Wilms' tumor. Hum Mutat 1999; 13: 146-153.
29. McMaster ML, Gessler M, Stanbridge EJ et al. WT1 expression alters tumorigenicity of the G401 kidney-derived cell line. Cell Growth Differ 1995; 6: 1609-1617
30. Desmet FO, Hamroun D, Lalande M et al. Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res 2009; 37: e67.
31. Cartegni L, Wang J, Zhu Z et al. ESEfinder: a web resource to identify exonic splicing enhancers. Nucleic Acids Res 2003; 31: 3568-3571.